Labcorp Holdings Inc. (FRA:N6B)
224.00
+2.00 (0.90%)
Last updated: Jul 29, 2025
Intra-Cellular Therapies Market Cap
Labcorp Holdings has a market cap or net worth of €18.78 billion as of August 1, 2025. Its market cap has increased by 11.96% in one year.
Market Cap
18.78B
Enterprise Value
23.90B
Revenue
11.48B
Ranking
n/a
PE Ratio
28.88
Stock Price
$224.00
Market Cap Chart
Since July 20, 1992, Labcorp Holdings's market cap has increased from 1.47B to 18.78B, an increase of 1,179.78%. That is a compound annual growth rate of 8.02%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 31, 2025 | 18.85B | 1.74% |
Dec 31, 2024 | 18.53B | 6.12% |
Dec 29, 2023 | 17.46B | -10.57% |
Dec 30, 2022 | 19.52B | -26.17% |
Dec 31, 2021 | 26.44B | 63.14% |
Dec 31, 2020 | 16.21B | 10.73% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 292.08B |
Siemens Aktiengesellschaft | 174.92B |
Deutsche Telekom AG | 153.20B |
Allianz SE | 132.59B |
Siemens Energy AG | 80.60B |
Rheinmetall AG | 78.24B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 73.00B |
Deutsche Bank Aktiengesellschaft | 55.70B |